Association of Tissue mRNA and Serum Antigen Levels of Members of the Urokinase-Type Plasminogen Activator System with Clinical and Prognostic Parameters in Prostate Cancer

Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches

(2012) Hideaki Miyake et al.   INTERNATIONAL JOURNAL OF UROLOGY

Toward the Detection of Prostate Cancer in Urine: A Critical Analysis

(2012) Matthew Truong et al.   JOURNAL OF UROLOGY

Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients

(2011) Matthias Kotzsch et al.   BMC CANCER

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

(2010) H Taubert et al.   BRITISH JOURNAL OF CANCER

Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

(2010) Manfred Schmitt et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

(2010) Karin Mengele et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

(2010) Isabell D. Witzel et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer

(2010) Charlotte E. Almasi et al.   PROSTATE

Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal Adenocarcinoma

(2009) Aiqun Xue et al.   PANCREAS

Significant Down-Regulation of the Plasminogen Activator Inhibitor 1 mRNA in Pancreatic Cancer

(2009) Ute Warnecke-Eberz et al.   PANCREAS

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS

Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers

(2008) S. F. Shariat et al.   CLINICAL CANCER RESEARCH

Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients

(2008) Amit Gupta et al.   EUROPEAN UROLOGY

Expression of urokinase-type plasminogen activator system in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

(2008) Masafumi Kumano et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS